Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prostate Cancer
100%
Prostate-specific Antigen
100%
Targeted Therapy
100%
Targeted Imaging
100%
PSMA Inhibitor
100%
Imaging Agents
50%
Therapeutic Agents
33%
Tumor
33%
LNCaP Cells
33%
Prostate Cancer Cells
33%
Tumor Xenograft
33%
Technetium-99m
33%
Malignancy
16%
Metastatic Disease
16%
Injected Dose
16%
Weight Loss
16%
Tumor Targeting
16%
Cell Tumor
16%
Targeting Ligands
16%
Endosome
16%
Improved Efficacy
16%
Accuracy Improvement
16%
Imaging Studies
16%
Muscle Ratio
16%
LNCaP Cell Line
16%
Radioimaging
16%
Human Prostate Cancer Cells
16%
IC50
16%
Biodistribution Studies
16%
Cells in Culture
16%
Advanced Disease
16%
Optical Imaging
16%
Causes of Mortality
16%
Rhodamine B (Rh B)
16%
Western Societies
16%
Metastasis Sites
16%
PSMA Negative
16%
Medicine and Dentistry
Prostate Cancer
100%
Prostate Specific Membrane Antigen
100%
Cancer Cell
33%
Neoplasm
22%
Metastatic Carcinoma
22%
Tumor Xenograft
22%
Technetium-99
22%
Diseases
11%
Cancer
11%
Therapeutic Agent
11%
Receptor
11%
Fluorescein Isothiocyanate
11%
Antiinfective Agent
11%
IC50
11%
Imaging Agent
11%
LNCaP Cell Line
11%
Optical Imaging
11%
Biodistribution
11%
Targeted Therapeutic Agent
11%
Endosome
11%
Rhodamine B
11%
Tenofovir
11%
Tumor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Prostate Specific Membrane Antigen
100%
Neoplasm
44%
Technetium 99m
22%
Diseases
11%
Receptor
11%
Fluorescein Isothiocyanate
11%
Antiinfective Agent
11%
IC50
11%
Biodistribution
11%
Optical Imaging
11%
Rhodamine B
11%
Tenofovir
11%